Connective Tissue Diseases Flashcards
DLE antibody
Anti-smith
Histo of DLE
interface dermatitis with lymphocytes
follicular plugging
perivascular and periadnexal infiltrate
increased mucin
DIF of DLE
continuous granular deposits of Ig and complement at DEJ
Where to biopsy DLE
Established lesional skin, but not burned-out scar
Lupus vulgaris
Cutaneous TB
DLE Treatment
First line: Sunscreen, Topical/IL steroids, Topical immunosuppressants
Second line: antimalarials, syst retinoids
Third line: cytotoxic agents, thalidomide, abx
Subacute LE Antibody
80% ANA +, speckled pattern
70% Ro/SSA +
HLA associated with SCLE
HLA-DR3
Drug-Induced SCLE
HANG NAIL HCTZ ACE-I and Antihistamines NSAIDs Griseofulvin Nifedipine Anticonvulsants Interferons Lamisil
Antibody in neonatal lupus
Ro/SSA
Antibody in neonatal lupus that spares congenital heart block
U1RNP
C4 deficiency
hyperkeratosis palms and soles
annular SCLE lesions
homozygous = SLE, mesangial glomerulonephritis, membranous nephropathy
Homozygous C2 deficiency
severe infections
SLE
atherosclerosis
SLE ACR Criteria
SOAP BRAIN MD (4+ criteria for dx) Sun sensitivity Oral ulcers Arthritis Pleuritis, pericarditis Blood (hemolytic anemia, thrombocytopenia, leukopenia) Renal ds ANA+ Immunologic (anti-dsDNA, anti-Smith, antiphospholipid) Neuro (seizures, psychosis) Malar rash Discoid rash
Rowell syndrome
SLE with erythema multiforme-like lesions
ASAP syndrome
Acute Syndrome of Apoptotic Pan-Epidermolysis associated with SLE
Bullous SLE HLA association
HLA-DR2
Bullous SLE antibodies
Type VII collagen antibodies
Bullous SLE histo
neutrophils at DEJ within dermal papillae
Bullous SLE treatment
Dapsone
Sneddon syndrome
AD in young women
livedo reticularis + cerebrovascular infarcts
due to hyalinaizing vasculopathy
may also have SLE
Hughes syndrome
antiphospholipid syndrome phenotype
SLE histo
vacuolar interface
mucinous
Antibodies specific for nephritis in SLE
anti-dsDNA, anti-C1q
Antibody for drug-induced SLE
antihistone
Drugs associated with drug-induced SLE
MMC is HIPP Methyldopa Minocycline Chlorpromazine Hydralazine Isoniazid Procainamide Phenytoin also TNF-alpha inhibitors induce ANA positivity Penacillamine unmasks SLE
DIF of SLE
granular IgG +/- IgM at DEJ
Lupus band
negative does not exclude diagnosis
non-lesional sun-exposed skin for bx
Gottron’s sign vs Gottron’s papules
Sign = violaceous atrophic patches of knuckles, knees, elbows Papules = lichenoid polygonal papules on knuckles
Cutaneous findings of Dermatomyositis
Heliotrope rash Gottron's sign Gottron's papules Poikiloderma (holster sign) Shawl sign Proximal nail fold telangiectasias Ragged cuticles/mechanics hands Calcinosis cutis
Antibodies of dermatomyositis
anti-Jo1 (antisynthetase) = reynaud’s, mechanic hands, interstitial lung ds
ANA 60-80%
anti-Mi-2 (anti-nuclear helicase) = good prognosis, shawl sign
Site of muscle biopsy for dermatomyositis
tricep or quad (not deltoid)
Markers to follow in dermatomyositis
CK, aldolase, ESR
Two types of childhood dermatomyositis
Brunsting (mc) = weakness, calcinosis, steroid responsive
Banker = vasculitis, GI, steroid unresponsive, high mortality
Childhood dermatomyositis gene
DQA1*0501
Dermatomyositis histo
atrophic epidermis
BMZ thickening
dermal mucin
perivascular and periadnexal lymphocytic infiltrate
Dermatomyositis Treatment
Prednisone 1mg/kg/day, slow long taper
methotrexate, myophenolate mofetil, azathioprine, IVIG, cyclosporin, tacrolimus, infliximab
Generalized morphea antibodies
antihistone (87%), anti-ssDNA
Anti-histone antibodies
generalized morphea, drug-induced SLE
Morphea histo
squared biopsy
atrophic epidermis
broad hyalinzed collagen bundles
lymphocytes and plasma cells
Atrophoderma of Pasini and Pierini presentation
brownish-gray, oval, atrophic lesions on posterior trunk of young women
Cliff drop sign
Asx
Risk of not treating morphea in children
impede limb development
Parry-Romberg Syndrome presentation
progressive hemifacial atrophy epilepsy exopthalmos alopecia hyperpigmentation followed by atrophy of dermis, SQ, fat, muscle, sometimes bone
Parry-Romberg Syndrome antibodies
anti-ssDNA
CREST antibody
anticentromere
Systemic sclerosis major and 3 minor criteria
Major: proximal scleroderma to MCP
Minor: sclerodactyly, digital pitting scars, b/l basilar pulm fibrosis
Pterygium inversum unguis
distal nailbed adherent to ventral nail plate in scleroderma
Systemic sclerosis antibodies
anti-topoisomerase (anti Scl-70)
ANA - antinucleolar
anti-RNP (raynaud, polyarthralgia)
Major cause of death in systemic sclerosis
Pulmonary disease
Systemic sclerosis histo
perivascular lymphocytic infiltrate with plasma cells at dermis-SQ junction
hyalinized collagen bundles
dermal sclerosis
loss of SQ fat
“pepper-dot” epidermal nuclear reaction in centromere positive
loss of CD34+ dendritic cells
Three possible causes of scleroderma
Borrelia infection
Genetic susceptibility: Fibrillin-1
Exposures: L-tryptophan, rapeseed oil
Scleroderma treatment
PT, quit smoking
UVA1
D-penicillamine
system specific therapies: nifedipine, ACE-I
Eosinophilic fasciitis presentation
after strenuous exercise
peau d’orange or pseudo-cellulite skin
“groove sign” or “dry river bed sign”
eosinophilia
Eosinophilic fasciitis labs
ESR, TGF-alpha1, eosinophilia
Eosinophilic fasciitis histo
patchy lymphohistiocytic & plasma cell infiltrate in fascia and muscle
thickening of fascia and SQ septae
Eosinophilic fasciitis treatment
systemic steroids, histamine blockers
usually complete recovery in 1-3 years
Another name for Mixed Connective Tissue Disease
Sharp’s Syndrome
Mixed connective tissue disease presentation
scleroderma, LE, DM, RA features hand edema (sausage digits), Raynaud's, arthritis, pulm ds